An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP

NCT04943042 · clinicaltrials.gov ↗

COMPLETED

Status

199

Enrollment

INDUSTRY

Sponsor class

Conditions

Immune Thrombocytopenia
ITP

Interventions

DRUG: Avatrombopag

Sponsor

Swedish Orphan Biovitrum